Farmakoekonomika jako narzędzie zarządzania zasobami ochrony zdrowia

• Autorzy: Marcin Czech

Warianty tytułu

Farmacoeconomics as a Tool of Health Care Resources Management

• Języki publikacji: PL

Abstrakty

Farmakoekonomika to ekonomiczna ocena środków farmaceutycznych. Z punktu widzenia zastosowania praktycznego, farmakoekonomika jest częścią ekonomiki zdrowia, która ma na celu optymalizację farmakoterapii, czyli dążenie do racjonalnego i oszczędnego gospodarowania lekami. W artykule zaprezentowano zasady farmakoekonomiki i możliwości jej wykorzystania w zarządzaniu systemem opieki zdrowotnej.

EN

According to WHO, proper evaluation of health-care programmes needs to take into consideration not only their efficacy and safety, but also their cost-effectiveness. Scarcity of resources in health-care systems triggered the necessity of economic assessment of medical procedures. Following international examples, economic evaluation of health-care programmes is starting to play an increasing role in Poland. Applying the broadest view, economic evaluation is defined as the comparative analysis of alternative courses of action in terms of their costs and consequences. This definition includes economic evaluation of prescribed drugs, summarised by the term pharmacoeconomics (from Greek „pharmacon" - drug, and Greek „oikonomia" - meaning saving, or Latin „oeconomia" - management). Pharmacoeconomics can be defined as the study of economic implications of drug usage. This can be used either to try to justify the use of drugs as an economic benefit or to evaluate the cost associated with a patient having a disease in comparison with the cost needed to treat the patient. From practical point of view, pharmacoeconomics is part of health economics, the aim of which is to optimise pharmacotherapy through rational drug management. The role of pharmacoeconomic research is to identify, measure, and compare the resources consumed and the corresponding costs with consequences in the form of clinical, humanistic, and economic outcomes of pharmaceutical products and services. The results of these studies serve as scientific evidence for decision making. (original abstract)

Słowa kluczowe

PL

Ochrona zdrowia; Koszty ochrony zdrowia; Rachunek kosztów

EN

Health care protection; Health costs; Cost accounting

• Czasopismo: Problemy Zarządzania
• Rocznik: 2004
• Tom: 2
• Numer: nr 4 (6) Farmakoekonomika
• Strony: 68--79

Twórcy

autor

Marcin Czech

Bibliografia

• Bootman J.L., Townsend R.J. i W. F. McGhan. 1996. Principles of Pharmacoeconomics. 2nd edition, New York: Harvey Whitney Book Company.
• Chmal-Jagiełło K., 2000, Farmakoekonomika, Wrocław, Uniwersytet Jagielloński Collegium Medicum.
• Czech M., Orlewska E., 2002. Słownik Farmakoekonomiczny, Wydanie II, Jaworzno: Unimed.
• Czech M., Piwek A. i J. Halik., 2001. Ocena jakości życia chorych na przewlekłą niewydolność żylną leczonymi różnymi metodami a ocena jakości świadczonych usług. Zdrowie Publiczne, nr 111(1), s. 20-25.
• Drummond M.E., O`Brien B., Stoddart G.L. i G.W. Torrance., 1997. Methods for the Economic Evaluation of Health Care Programmes, Second Edition. Oxford: Oxford University Press.
• Getzen T.E., 2002. Ekonomika Zdrowia, Warszawa: Wydawnictwo Naukowe PWN.
• Kopaliński W., 1990. Słownik wyrazów obcych i zwrotów obcojęzycznych. Warszawa: Wiedza Powszechna.
• Sloan F.A., 1996. Valuing Health Care. Costs, Benefits and Effectiveness of Pharmaceuticals and Other Medical Technologies, Cambridge: Cambridge University Press.
• Spilker B., 1996. Quality of Life and Pharmacoeconomics in Clinical Trials. Philadelphia: Lippincott-Raven.